v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Conversion of Convertible Notes
Common stock
Common stock
Conversion of Convertible Notes
Additional paid in capital
Additional paid in capital
Conversion of Convertible Notes
Acc. other comprehensive (loss) income
Treasury stock
Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2024     251,554,378            
Beginning balance at Dec. 31, 2024 $ (3,714)   $ 26   $ 625,130   $ 121 $ (57,350) $ (571,641)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net loss (61,986)               (61,986)
Foreign currency translation adjustments, net of tax 12           12    
Unrealized losses on available for sale investments, net 0                
Equity-based compensation expense 7,400       7,400        
Exercise of options (in shares)     983,434            
Exercise of options 1,393       1,393        
Issuance of shares for equity-based compensation awards, net (in shares)     3,120,222            
Issuance of shares for equity-based compensation awards, net (1,316)   $ 2   (1,318)        
Proceeds from exercise of warrants (in shares)     14,800,000            
Proceeds from exercise of warrants 113,953   $ 1   113,952        
Issuance of shares for exercised convertible notes (in shares)       16,658,335          
Issuance of shares for exercised convertible notes   $ 135,599   $ 2   $ 135,597      
Issuance of shares from at-the-market offering (in shares)     1,936,000            
Issuance of shares from at-the-market offering 6,454       6,454        
Ending balance (in shares) at Mar. 31, 2025     289,052,369            
Ending balance at Mar. 31, 2025 $ 197,795   $ 31   888,608   133 (57,350) (633,627)
Beginning balance (in shares) at Dec. 31, 2025 446,908,458   436,955,655            
Beginning balance at Dec. 31, 2025 $ 611,870   $ 46   1,534,792   (63) (57,350) (865,555)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net loss (56,763)               (56,763)
Foreign currency translation adjustments, net of tax 118           118    
Unrealized losses on available for sale investments, net (818)           (818)    
Equity-based compensation expense $ 3,423       3,423        
Exercise of options (in shares) 36,489   36,489            
Exercise of options $ 67       67        
Issuance of shares for equity-based compensation awards, net (in shares)     1,951,933            
Issuance of shares for equity-based compensation awards, net (850)       (850)        
Issuance of shares for exercised convertible notes (in shares)     38,069,987            
Issuance of shares for exercised convertible notes 233,358   $ 3   233,355        
Retirement of treasury stock $ 0       (57,350)     57,350  
Ending balance (in shares) at Mar. 31, 2026 477,014,064   477,014,064            
Ending balance at Mar. 31, 2026 $ 790,405   $ 49   $ 1,713,437   $ (763) $ 0 $ (922,318)